Yale partners with pharma giant to launch biomedical data science fellowship program

New Haven, Conn.-based Yale University is partnering with pharmaceutical company Boehringer Ingelheim to launch a Biomedical Data Science Fellowship program aimed at innovating drug discovery.

A May 10 news release said the fellowship will help clinicians and pharmaceutical companies identify potential new pathways for treatment and eradication of diseases.

Five things to know:

  1. The three-year fellowship will give post-doctoral researchers access to Yale's computational resources, biomedical data repositories and faculty expertise. Fellows will also have access to Boehringer Ingelheim's corporate labs, scientists and executives.

  2. Applicants are invited to submit research proposals for consideration by June 15. Three fellowships will be awarded each year until nine are selected in the first five years.

  3. Selected fellows will be jointly mentored by Yale researchers and Boehringer Ingelheim.

  4. The program will be based at the Yale Center for Biomedical Data Science, and fellowship training will begin Sept. 1.

  5. The program aims to harness data science to transform drug discovery and development.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars